Australian biotech market today 28.04.09
Tuesday, 28 April, 2009
The healthcare indices are up a very healthy 2.6 per cent on the market at 3.00pm on a day when other shares lost yesterday’s gains.
Biota (ASX:BTA) is down a touch following its massive rise yesterday, when shares shot up 80 per cent. It has settled at a very respectable $1.50 today.
Investors obviously like the look of any stocks with a whiff of swine flu, as vaccine developer CSL (ASX:CLS) is up $1.15 to $33.
In terms of the other majors, Cochlear (ASX:COH) is up $1 while ResMed (ASX:RMD) is up 3c.
Hexima (ASX:HXL) is up 3c to 45c – see our profile of the agbiotech company, published today.
Alchemia (ASX:ACL) is almost 19 per cent, while Mesoblast (ASX:MSB) is down 4c to 73c.
Defective sperm doubles pre-eclampsia risk in IVF patients
A high proportion of the father's spermatozoa possessing DNA strand breaks is associated with...
Free meningococcal B vaccines coming to the NT
The Northern Territory Government has confirmed the rollout of a free meningococcal B vaccine...
Mouth bacteria linked to increased head and neck cancer risk
More than a dozen bacterial species that live in people's mouths have been linked to a...
